lithium-chloride and Amnesia

lithium-chloride has been researched along with Amnesia* in 4 studies

Other Studies

4 other study(ies) available for lithium-chloride and Amnesia

ArticleYear
Blockade of conditioned taste aversion by scopolamine and N-methyl scopolamine: associative conditioning, not amnesia.
    Psychopharmacology, 1992, Volume: 106, Issue:2

    The anticholinergic, scopolamine, consistently disrupts one-trial passive avoidance conditioning but the effects of such drugs on one-trial conditioned taste aversion (CTA) are variable and contradictory. In the present study, treatment of rats with scopolamine impaired the suppression of sucrose intake by post-ingestion administration of lithium chloride (LiCl) in a two-bottle choice test. A similar effect was obtained by using N-methyl scopolamine which penetrates the brain only to a limited degree on acute administration. The blockade of CTA could be prevented in three ways: (i) by exposing the rats to sucrose only on the training day, (ii) by pre-exposing the rats to both sucrose and scopolamine, and (iii) by using a less palatable sucrose/ascorbate mixture. The results demonstrate that the effect of scopolamine on taste aversion is not mediated by the central nervous system, and can be modified by altering the novelty and relative salience of the taste conditioned stimulus. These experiments suggest that conditioned associations between taste and LiCl, and scopolamine and LiCl may underlie the blockade of CTA by scopolamine.

    Topics: Amnesia; Animals; Ascorbic Acid; Avoidance Learning; Chlorides; Conditioning, Operant; Lithium; Lithium Chloride; Male; N-Methylscopolamine; Neostigmine; Parasympatholytics; Physostigmine; Rats; Rats, Inbred Strains; Scopolamine; Scopolamine Derivatives; Sucrose; Taste

1992
Amnesia produced by anisomycin in an appetitive task is not due to conditioned aversion.
    Behavioral and neural biology, 1987, Volume: 47, Issue:1

    Two experiments investigated the effects of lithium chloride (LiCl) and anisomycin (ANI) in a water reward Y-maze task. In Experiment 1, male CD-1 mice given weak or strong training were injected post-training with either saline or LiCl (150 mg/kg), which has been reported to produce conditioned aversion in mice. One day after training, both LiCl groups avoided the rewarded arm of the maze and drank less water than saline-injected controls. Two days after training, the strongly trained LiCl mice showed avoidance, while both LiCl groups drank less water. In Experiment 2, weakly trained mice given pre- and post-training ANI (30 mg/kg) were amnesic on the second test day compared to mice that received post-trial saline. However, water consumption was increased on the test day for both groups. LiCl produced a different pattern of results than ANI in this task. On the basis of these results, it is suggested that amnesia produced by ANI is due to impaired memory formation and not to conditioned aversion.

    Topics: Amnesia; Animals; Anisomycin; Appetitive Behavior; Avoidance Learning; Chlorides; Drinking Behavior; Lithium; Lithium Chloride; Male; Memory; Mice; Mice, Inbred Strains; Pyrrolidines

1987
Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam.
    Journal of medicinal chemistry, 1984, Volume: 27, Issue:5

    A series of N-[(dialkylamino)alkyl]-2-oxo-1- pyrrolidineacetamides was synthesized. The title compounds reversed electroconvulsive shock (ECS) induced amnesia in mice when administered subsequent to the ECS treatment and were inactive in a general observational test for central nervous system (CNS) activity. Active compounds exhibited an inverted U-shaped dose-response curve. Among the compounds with the broadest dose-response curve, as well as the most potent, were those with the N-[2-[bis(1-methylethyl)amino] ethyl] or 2,6- dimethylpiperidinoethyl residues as amide substituent. The N-(dialkylamino) substituent markedly enhances amnesia-reversal activity, with ethylene providing the optimal chain length. N-[2-[Bis(1-methylethyl)amino]ethyl] -2-oxo-1- pyrrolidineacetamide N-(dialkylamino) substituent was selected for preclinical toxicological evaluation, assigned the investigational number CI-879 and the U.S. adopted name ( USAN ) pramiracetam . Pramiracetam demonstrated a wide margin of safety in animals and was well tolerated in normal human volunteers. It has shown encouraging activity in an open label trial in patients with primary degenerative dementia (PDD or senile dementia of the Alzheimer's type).

    Topics: Amnesia; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroshock; Humans; Male; Mice; Mice, Inbred Strains; Pyrrolidines; Structure-Activity Relationship

1984
Protein synthesis and memory: a review.
    Psychological bulletin, 1984, Volume: 96, Issue:3

    Topics: Adrenal Cortex Hormones; Amnesia; Animals; Anisomycin; Brain; Catecholamines; Chlorides; Conditioning, Classical; Cycloheximide; Humans; Learning; Lithium; Lithium Chloride; Memory; Memory, Short-Term; Mice; Nerve Tissue Proteins; Puromycin; Retention, Psychology; Time Factors

1984